Clinical Trial Detail

NCT ID NCT02905994
Title Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

acute myeloid leukemia

Therapies

Cytarabine + Idarubicin + Volasertib

Age Groups: senior adult

No variant requirements are available.